Skip to content

Volker Huppert

  • Chief Development Officer
  • Glycostem Therapeutics B.V.
  • 10h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 361CitationsNumber of citations received by Volker's publications. Updated daily.

Recent publications

  • Granzin_Cytotherapy_Figures

  • Optimization of human NK cell manufacturing: Fully-automated separation, improved <i>ex vivo </i>expansion using IL-21 with autologous feeder cells and generation of anti-CD123-CAR-expressing effector cells.

    • Klöß S
    • Oberschmidt O
    • Morgan M
    • et al.
    Get full text

Professional experience

Chief Development Officer

Glycostem Therapeutics B.V.

March 2018 - Present

Manager R&D Reagents C3

Miltenyi Biotec GmbH

August 2016 - February 2018(2 years)

Project Leader Research & Development

Miltenyi Biotec GmbH

February 1999 - May 2007(8 years)

Project Engineer

Miltenyi Biotec GmbH

January 1998 - February 1999(a year)

Quality Assurance / Document Contol

AmCell GmbH

July 1996 - December 1997(a year)


Bierbotschafter (IHK)

Gastronomisches Bildungszentrum Koblenz

June 2018


Aachen University of Technology (RWTH)

September 1990 - May 1996(6 years)